Osteoporosis finds easy victims among HIV patients

By admin | Mar 30, 2010

Though the introduction of HAART (Highly Active Antiretroviral Therapy) has improved the survival and quality of life for people infected with the human immunodeficiency virus (HIV-1), yet this improved prognosis has also resulted in long term negative disorders, namely osteoporosis.
A study published in the Spanish review Enfermedades Infecciosas y MicrobiologĂ­a ClĂ­nica [Infectious Diseases and Clinical [...]






Medication discontinuation risk higher in patients new to chronic disease medication

By admin | Mar 25, 2010

Patients new to chronic disease medication are at an increased of facing the greatest risk of medication discontinuation during the first 30 days of treatment - with discontinuation rates ranging from 29.6 to 78.1 percent, as per researchers from Adheris, Inc., an inVentiv Health.
This finding was disclosed by a new study that was published online [...]






Patients affected with multiple myeloma get relief from steroid pills

By admin | Mar 21, 2010

According to researchers at the Cedars-Sinai Medical Center, steroid pills are effective for improving the overall survival rate of individuals affected by multiple myeloma.
Multiple myeloma is a cancer of the plasma cells in the bone marrow.
James Berenson, M.D., lead author of the Southwest Oncology Group sponsored study and Director of the Multiple Myeloma and Bone [...]






FSGS treatment possible with antidiabetes drug

By admin | Mar 20, 2010

The antidiabetes drug, Rosiglitazone, may prove its efficacy for protecting kidney function in patient suffering from a complication called focal segmental glomerulosclerosis (FSGS).
The finding was disclosed in a study that appeared in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN).
From News-Medical.Net:
The investigators studied 11 patients with FSGS whose condition [...]






Corticosteroids not good for improving patient survival rate

By admin | Mar 17, 2010

When it comes to improving the patient survival rate in people struggling against acute respiratory distress syndrome (ARDS), corticosteroids are not
effective options.
The finding was a part of results from the ARDS Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
From News-Medical.Net:
“These findings provide important information [...]






Omalizumab may come with a warning label, FDA recommends

By admin | Mar 12, 2010

The Food and Drug Administration (FDA) has requested Genentech, Inc. for a boxed warning on the product label for omalizumab, marketed as Xolair.
This warning is concerned about a potential side effect, anaphylaxis. Anaphylaxis may include troubled breathing, chest tightness, dizziness, fainting, itching, and hives.
Genentech was asked by the FDA to provide a Medication Guide for [...]






Doctor accused in drug case accepts plea

By admin | Mar 8, 2010

A California-based doctor accused of offering Major League Baseball players with performance-enhancing drugs has pleaded guilty to the accusations.
Ramon Scruggs, the doctor, made the confession after being accused of illegally writing prescriptions to patients.
The plea agreement came from federal prosecutors at the United States District Court in San Jose.
From NYTimes.com:
The New York Times reported in [...]






Worm hormone discovery may assist fight against parasitic disease

By admin | Mar 4, 2010

Nematodes, hormone-like molecules in tiny worms, work on the same line as certain human hormones - a finding that may one day prove to be useful to eliminate worm infections that tend to affect a third of the world population.
Researchers from the UT Southwestern discovered a molecule, which can be termed responsible to activate the [...]






© 2008 Educational College